Literature DB >> 10981090

Issues of clinical trial design and data interpretations in hypertension.

L H Kuller1.   

Abstract

There are many drug studies for the treatment of hypertension. Most studies compare one drug with another to determine if a drug or class of drugs have unique benefits. In evaluating drug trials, separation of hypertension as compared with atherosclerotic events is important. Trials that focus on prevention of hypertension, especially with new noninvasive markers, may have a bigger part in reducing morbidity and mortality due to elevated blood pressure.

Entities:  

Mesh:

Substances:

Year:  1999        PMID: 10981090     DOI: 10.1007/s11906-999-0046-1

Source DB:  PubMed          Journal:  Curr Hypertens Rep        ISSN: 1522-6417            Impact factor:   5.369


  25 in total

1.  1999 World Health Organization-International Society of Hypertension Guidelines for the Management of Hypertension. Guidelines Subcommittee.

Authors: 
Journal:  J Hypertens       Date:  1999-02       Impact factor: 4.844

Review 2.  Goals of antihypertensive treatment: prevention of cardiovascular events and prevention of organ damage.

Authors:  A Zanchetti
Journal:  Blood Press       Date:  1992-12       Impact factor: 2.835

Review 3.  The hypertension trials.

Authors:  P S Sever; J A Mackay
Journal:  J Hypertens Suppl       Date:  1996-09

4.  End-stage renal disease in African-American and white men. 16-year MRFIT findings.

Authors:  M J Klag; P K Whelton; B L Randall; J D Neaton; F L Brancati; J Stamler
Journal:  JAMA       Date:  1997 Apr 23-30       Impact factor: 56.272

5.  Effect of antihypertensive drug treatment on cardiovascular outcomes in women and men. A meta-analysis of individual patient data from randomized, controlled trials. The INDANA Investigators.

Authors:  F Gueyffier; F Boutitie; J P Boissel; S Pocock; J Coope; J Cutler; T Ekbom; R Fagard; L Friedman; M Perry; R Prineas; E Schron
Journal:  Ann Intern Med       Date:  1997-05-15       Impact factor: 25.391

Review 6.  Prevention of a first stroke: a review of guidelines and a multidisciplinary consensus statement from the National Stroke Association.

Authors:  P B Gorelick; R L Sacco; D B Smith; M Alberts; L Mustone-Alexander; D Rader; J L Ross; E Raps; M N Ozer; L M Brass; M E Malone; S Goldberg; J Booss; D F Hanley; J F Toole; N L Greengold; D C Rhew
Journal:  JAMA       Date:  1999 Mar 24-31       Impact factor: 56.272

7.  Relationship between ApoE, MRI findings, and cognitive function in the Cardiovascular Health Study.

Authors:  L H Kuller; L Shemanski; T Manolio; M Haan; L Fried; N Bryan; G L Burke; R Tracy; R Bhadelia
Journal:  Stroke       Date:  1998-02       Impact factor: 7.914

Review 8.  Seven lessons from two candidate genes in human essential hypertension: angiotensinogen and epithelial sodium channel.

Authors:  P Corvol; A Persu; A P Gimenez-Roqueplo; X Jeunemaitre
Journal:  Hypertension       Date:  1999-06       Impact factor: 10.190

9.  Untreated blood pressure level is inversely related to cognitive functioning: the Framingham Study.

Authors:  M F Elias; P A Wolf; R B D'Agostino; J Cobb; L R White
Journal:  Am J Epidemiol       Date:  1993-09-15       Impact factor: 4.897

Review 10.  The importance of left ventricular hypertrophy in human hypertension.

Authors:  T Kahan
Journal:  J Hypertens Suppl       Date:  1998-09
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.